Intravesical chemotherapy involves a healthcare professional injecting chemotherapy medication directly into the bladder to treat cancerous tumors. “Intravesical” means “within the bladder.” ...

Neoadjuvant cisplatin-based chemotherapy plus chemoradiotherapy offers a safe, effective bladder-sparing approach with promising long-term outcomes in nonmetastatic MIBC. Median disease-free survival ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...

Bladder cancer affects 75,000 people in this country every year, but treating it can bring drastic change to patients. So now, Bay Area surgeons are offering a new option -- the neobladder procedure.

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

A genetic mutation in one of three genes associated with DNA damage repair was associated with improved outcomes to presurgical chemotherapy in localized muscle-invasive bladder cancer, according to ...

BARCELONA, Spain — Health-related quality of life (HRQoL) is not further compromised by the addition of nivolumab (Opdivo) immunotherapy to first-line cisplatin-based chemotherapy in patients with ...

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...

Robot-assisted surgery for bladder cancer will be compared to traditional open surgery in 14 institutions nationwide, thanks to a five-year, $3.1 million National Cancer Institute grant awarded to Dr.